Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | APEX1 | P27695 | 3/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.40 |
| ▸ | CNR1 | P21554 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PTGES | O14684 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP3 | P08254 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17627791 | 0.93 | TDP1 (0.56) | TDP1ALOX5TAS1R3TAS1R1MMP1 | |
| SCHEMBL5198950 | 0.93 | TDP1 (0.56) | TDP1ALOX5TAS1R3TAS1R1MMP1 | |
| SCHEMBL126604 | 0.93 | TDP1 (0.56) | TDP1ALOX5TAS1R3TAS1R1MMP1 | |
| SCHEMBL39941 | 0.87 | APEX1 (0.53) | TDP1ALOX5APEX1CNR1PPARG | |
| SCHEMBL2489081 | 0.87 | APEX1 (0.53) | TDP1ALOX5APEX1CNR1PPARG | |
| SCHEMBL9301856 | 0.87 | APEX1 (0.53) | TDP1ALOX5APEX1CNR1PPARG | |
| 4-Methoxycinnamic Acid SCHEMBL1548518 | 0.86 | TDP1 (0.60) | TDP1TAS1R3TAS1R1THRB | |
| SCHEMBL2490383 | 0.86 | ALOX5 (0.54) | TDP1ALOX5APEX1CNR1PPARG | |
| SCHEMBL7181298 | 0.86 | TDP1 (0.42) | TDP1ALOX5TAS1R3TAS1R1CNR1 | |
| Octinoxate SCHEMBL29435124 | 0.84 | TDP1 (0.76) | TDP1ALOX5TAS1R3TAS1R1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3257497-B1 | ANTIOXIDANT AGENT, ANTIOXIDANT COSMETIC AND UV CARE COSMETIC BASED ON ENZYMATICALLY SYNTHESIZED GLYCOGEN OR AN ALPHA-AMYLASE DIGEST THEREOF | EZAKI GLICO CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| EP-4356897-A1 | POWDER COSMETIC AND PRODUCTION METHOD FOR SAME | Shiseido Company, Ltd. (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2023190190-A1 | OILY COMPOSITION AND COSMETIC PREPARATION | 日清オイリオグループ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-10286005-B2 | Antioxidant agent, and antioxidant cosmetic and UV care cosmetic | EZAKI GLICO CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20180000856-A1 | ANTIOXIDANT AGENT, AND ANTIOXIDANT COSMETIC AND UV CARE COSMETIC | EZAKI GLICO CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| EP-3257497-A1 | ANTIOXIDANT AGENT, AND ANTIOXIDANT COSMETIC AND UV CARE COSMETIC | Ezaki Glico Co., Ltd. (JP) | 2017-12-20 | — | — | EP | disclosed |
| US-20120201775-A1 | HAIR STYLING COSMETIC | SHISEIDO COMPANY LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| EP-2468244-A1 | HAIR-DRESSING COSMETIC | Shiseido Company, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-20060257436-A1 | Skin preparation composition for external use | SHISEIDO COMPANY, LTD. (JP) | 2006-11-16 | — | — | US | disclosed |
| EP-1614351-A1 | SKIN PREPARATION COMPOSITION FOR EXTERNAL USE | SHISEIDO COMPANY, LTD. (JP) | 2006-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060257436-A1 | Skin preparation composition for external use | CUTA, KRT18, CYP24A1 | TDP1 2996/4885ALOX5 1411/4885APEX1 3755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.